Polifarmacy And The Compliance of Geriatric With Chronic Disease
DOI:
https://doi.org/10.25273/pharmed.v1i2.3285Abstract
The various geriatric’s health problem require complex treatment, which is by giving various drugs. Therefore, polifarmacy is a concequences of geriatric’s treatment. Polipharmacy is a serious problem in a health system. Besides can increase the health cost, also it can cause compliance problem. The purpose of this research is to see an overview the compliance level of geriatrics with chronic disease who receive a polipharmacy prescription. This is a descriptive research with cross sectional design. Data were obtained from outpatient prescriptions of geriatric’s with chronic disease in Yogyakarta’s hospital. From 100 prescriptions, there were 50 male and 50 female patients. In this research, most patients recieve 2 diagnoses (51%) and 48% polypharmacy prescription.  After the interview using MMAS 8 questionnare, there were 61% uncompliance geriatric’s patient , however the polypharmacy prescription isn’t significantly related to the patient’s compliance level.
Â
Keywords: Polipharmacy, geriatrics, chronic diseaseDownloads
Downloads
Published
Issue
Section
License
With the receipt of the article by Pharmed Editorial Board and the decision to be published, the copyright regarding the article will be transferred to Pharmed Journal.
Pharmed has the right to multiply and distribute the article and every author is not allowed to publish the same article that was published in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.